NCT00056498 Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine Status COMPLETED Phase PHASE4
NCT00053703 Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) Status COMPLETED Phase PHASE4
NCT00051298 Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia Status COMPLETED Phase PHASE3
NCT00051233 Treatment of Schizophrenia Through Internet-Based Psychoeducation Status COMPLETED Phase PHASE2
NCT00044187 The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder Status COMPLETED Phase PHASE4
NCT00044083 Clinical Trial of Tolcapone for Cognition in Schizophrenia Status TERMINATED Phase PHASE2
NCT00044044 A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT00044005 Safety and Tolerability Study of Drug to Treat Schizophrenia Status COMPLETED Phase PHASE2
NCT00042224 Electroconvulsive Therapy in Clozapine Refractory Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT00042159 Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations Status COMPLETED Phase NA
NCT00036127 Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders Status COMPLETED Phase PHASE2/PHASE3